Ken H. Dahlberg
Geen lopende functies
Profiel
Mr. Ken H.
Dahlberg is a Principal at Carefree Capital, Inc.
Prior to joining Carefree Capital, Mr. Dahlbrg served as Chairman of Buffalo Wild Wings, Inc. from June 1995 to April 2008.
Previously, he was Chief Executive Officer of Buffalo Wild Wings from June 1995 to January 2004.
He was Founder and Chairman of Dahlberg, Inc. from 1948 to 1993.
Eerdere bekende functies van Ken H. Dahlberg
Bedrijven | Functie | Einde |
---|---|---|
Carefree Capital, Inc.
Carefree Capital, Inc. Investment ManagersFinance Carefree Capital, Inc. is a venture capital firm located in Wayzata, Minnesota | Voorzitter | 26-05-2011 |
BUFFALO WILD WINGS | Directeur/Bestuurslid | 11-04-2008 |
Dahlberg, Inc.
Dahlberg, Inc. Medical SpecialtiesHealth Technology Part of Bausch Health Cos., Inc., Dahlberg, Inc. is a company that produces hearing aids. The company is based in Golden Valley, MN. Dahlberg was acquired by Bausch & Lomb, Inc., part of Bausch Health Cos., Inc. from May 16, 2007 on August 03, 1993 for $139 million. | Voorzitter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Buffalo Wild Wings, Inc.
Buffalo Wild Wings, Inc. RestaurantsConsumer Services Buffalo Wild Wings, Inc. owns, operates, and franchises restaurants. The company was founded by Jim Disbrow and Scott A. Lowery in 1982 and is headquartered in Atlanta, GA. | Consumer Services |
Carefree Capital, Inc.
Carefree Capital, Inc. Investment ManagersFinance Carefree Capital, Inc. is a venture capital firm located in Wayzata, Minnesota | Finance |
Dahlberg, Inc.
Dahlberg, Inc. Medical SpecialtiesHealth Technology Part of Bausch Health Cos., Inc., Dahlberg, Inc. is a company that produces hearing aids. The company is based in Golden Valley, MN. Dahlberg was acquired by Bausch & Lomb, Inc., part of Bausch Health Cos., Inc. from May 16, 2007 on August 03, 1993 for $139 million. | Health Technology |